Nan Li
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
Papers in
- Oncology 67
- Peptidase Inhibition and Analysis 27
- Cancer Immunotherapy and Biomarkers 18
-
- Medical Imaging Techniques and Applications 21
- Radiopharmaceutical Chemistry and Applications 19
- Radiomics and Machine Learning in Medical Imaging 10
- Co-authors
- Zhi Yang (52 shared papers)Hua Ping Zhu (49 shared papers)Yifan Wang (1 shared paper)Shinya Neri (1 shared paper)Weiye Deng (1 shared paper)Steven Hsesheng Lin (1 shared paper)Amrish Sharma (1 shared paper)Wen Jiang (1 shared paper)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (12 papers)Frontiers in Oncology (10 papers)Journal of Nuclear Medicine (8 papers)Molecular Pharmaceutics (6 papers)European Journal of Radiology (4 papers)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Nan Li
150 papers receiving 3.0k citations
Nan Li's Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 1.0k
- Radiology, Nuclear Medicine and Imaging 729
- Cancer Research 454
- Immunology 472
- Pulmonary and Respiratory Medicine 547
Countries citing papers authored by Nan Li
This map shows the geographic impact of Nan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Li more than expected).
Fields of papers citing papers by Nan Li
This network shows the impact of papers produced by Nan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Li. The network helps show where Nan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Nan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 162 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 322 | |
| 2 | 2018 | 313 | |
| 3 | 2021 | 112 | |
| 4 | 2021 | 98 | |
| 5 | 2013 | 82 | |
| 6 | 2020 | 78 | |
| 7 | 2018 | 76 | |
| 8 | 2018 | 72 | |
| 9 | 2023 | 70 | |
| 10 | 2020 | 67 | |
| 11 | 2020 | 65 | |
| 12 | 2018 | 61 | |
| 13 | 2018 | 57 | |
| 14 | 2022 | 56 | |
| 15 | 2014 | 53 | |
| 16 | 2020 | 45 | |
| 17 | SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade Hit paper breakdown → | 2025 | 45 |
| 18 | 2007 | 43 | |
| 19 | 2022 | 42 | |
| 20 | 2021 | 39 |
About Nan Li
Nan Li is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 162 papers that have together received 3.1k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (27 papers), Medical Imaging Techniques and Applications (21 papers), Radiopharmaceutical Chemistry and Applications (19 papers), Cancer Immunotherapy and Biomarkers (18 papers), Protease and Inhibitor Mechanisms (12 papers), Lung Cancer Diagnosis and Treatment (11 papers), Neuroendocrine Tumor Research Advances (10 papers) and Radiomics and Machine Learning in Medical Imaging (10 papers). The work is most often cited by research in Oncology (1.0k citations), Radiology, Nuclear Medicine and Imaging (729 citations), Cancer Research (454 citations), Immunology (472 citations) and Pulmonary and Respiratory Medicine (547 citations). Nan Li has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Zhi Yang, Hua Ping Zhu, Yifan Wang, Shinya Neri, Weiye Deng, Steven Hsesheng Lin, Amrish Sharma, Wen Jiang, Teli Liu and Xin Mei Zhou. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Frontiers in Oncology, Journal of Nuclear Medicine, Molecular Pharmaceutics and European Journal of Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.